A01N37/12

Carmustine pharmaceutical composition
10869848 · 2020-12-22 · ·

The present invention provides pharmaceutical formulations of lyophilized carmustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized carmustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with carmustine, such as neoplastic diseases.

Biofilm penetrating compositions and methods

Compositions are provided that have at least two of three active ingredients. The active ingredients maybe a salt having a cation N.sup.C8-C16 alkanoyl-L di-basic amino acid C1-C4 alkyl ester, a glycerol monoester of a fatty acid and a sugar ester of a fatty acid. The compositions are useful in methods of killing or inhibiting planktonic bacteria or fungi and bacteria or fungi embedded in a biofilm and prevention of biofilm formation on surfaces. The composition may further comprise a hydrogel and a benefit agent such as an antibiotic that can be solubilized by the hydrogel and supplied to the biofilm matrix by the active ingredients of the composition. Devices such as chronic wound coverings coated with the composition are also provided. Methods of preserving products with the composition are also provided.

Biofilm penetrating compositions and methods

Compositions are provided that have at least two of three active ingredients. The active ingredients maybe a salt having a cation N.sup.C8-C16 alkanoyl-L di-basic amino acid C1-C4 alkyl ester, a glycerol monoester of a fatty acid and a sugar ester of a fatty acid. The compositions are useful in methods of killing or inhibiting planktonic bacteria or fungi and bacteria or fungi embedded in a biofilm and prevention of biofilm formation on surfaces. The composition may further comprise a hydrogel and a benefit agent such as an antibiotic that can be solubilized by the hydrogel and supplied to the biofilm matrix by the active ingredients of the composition. Devices such as chronic wound coverings coated with the composition are also provided. Methods of preserving products with the composition are also provided.

Efficacy-enhancing agent composition for amino acid-based agrochemicals
10827746 · 2020-11-10 · ·

The present invention is an efficacy-enhancing agent composition for amino acid-based agrochemicals, containing, in a specific ratio, specific three quaternary ammonium salts having an ester group, and a specific fatty acid.

Efficacy-enhancing agent composition for amino acid-based agrochemicals
10827746 · 2020-11-10 · ·

The present invention is an efficacy-enhancing agent composition for amino acid-based agrochemicals, containing, in a specific ratio, specific three quaternary ammonium salts having an ester group, and a specific fatty acid.

Efficacy-enhancing agent composition for amino acid-based agrochemicals
10827746 · 2020-11-10 · ·

The present invention is an efficacy-enhancing agent composition for amino acid-based agrochemicals, containing, in a specific ratio, specific three quaternary ammonium salts having an ester group, and a specific fatty acid.

OVITRAP AND METHOD OF CONTROLLING VECTOR BORN DISEASE
20200344992 · 2020-11-05 ·

The present disclosure relates to an ovitrap and a method of controlling mosquito populations. The ovitrap includes a container, a cover, and a dividing mechanism for dividing the container into two regions, which in use are filled with water, and which communicate via an opening such that a first volume below the dividing mechanism defines a larvae trapping region, and a second volume above the dividing mechanism defines an egg receiving region A light source having a cool, white spectra with two peaks is mounted above the container and positioned to direct light downwards at a water surface, such that the larvae move in a direction away from the light source, from the second volume into the first volume below the dividing mechanism via the opening. A gating mechanism is operatively linked to the light source for opening and closing the opening.

OVITRAP AND METHOD OF CONTROLLING VECTOR BORN DISEASE
20200344992 · 2020-11-05 ·

The present disclosure relates to an ovitrap and a method of controlling mosquito populations. The ovitrap includes a container, a cover, and a dividing mechanism for dividing the container into two regions, which in use are filled with water, and which communicate via an opening such that a first volume below the dividing mechanism defines a larvae trapping region, and a second volume above the dividing mechanism defines an egg receiving region A light source having a cool, white spectra with two peaks is mounted above the container and positioned to direct light downwards at a water surface, such that the larvae move in a direction away from the light source, from the second volume into the first volume below the dividing mechanism via the opening. A gating mechanism is operatively linked to the light source for opening and closing the opening.

Methods of prediction of wound healing

Methods of detecting a local infection, critical colonization, or infection in a wound, predicting wound healing in a wound, and detecting bacterial pathogenesis in a wound are provided.

ANTIMICROBIAL, ANTIBACTERIAL AND SPORE GERMINATION INHIBITING ACTIVITY FROM AN AVOCADO EXTRACT ENRICHED IN BIOACTIVE COMPOUNDS

The present disclosure relates to extracts from Persea sp. (avocado) enriched in bioactive compounds which can be used as antimicrobial, antibacterial or spore germination inhibiting agents, the process for obtaining the extracts, acetogenins and isolated molecules and methods for using the extracts enriched in bioactive compounds for providing antimicrobial, antibacterial or spore germination inhibiting effect.